Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating leucopenia

A leukopenia and composition technology, applied in the field of medicine, can solve problems such as large side effects, high price, and restrictions on drug promotion

Inactive Publication Date: 2013-04-24
朱家红
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine often uses drugs such as batalinol, lexogen, and Ruibai for treatment, but the curative effect is poor and the side effects are relatively large
Although the granulocyte colony factor used in recent years has a certain curative effect, it is expensive and has many side effects, which limits the promotion of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] 5 parts of American ginseng, 3 parts of Astragalus, 2 parts of Panax notoginseng, 3 parts of Ganoderma lucidum

[0038] Ligustrum lucidum 3 parts Caulis Spatholobus 6 parts Lycium barbarum 3 parts Paeoniae Alba 3 parts

[0039] 3 parts of psoralen, 2 parts of donkey-hide gelatin, 3 parts of tangerine peel

Embodiment 2

[0041] 8 parts of American Ginseng, 5 parts of Astragalus, 5 parts of Panax notoginseng, 8 parts of Ganoderma lucidum

[0042] 8 parts of Ligustrum lucidum, 10 parts of Caulis Spatholobus, 8 parts of medlar, 8 parts of white peony

[0043] 8 parts of psoralen, 5 parts of donkey-hide gelatin, 8 parts of tangerine peel

Embodiment 3

[0045] 6 parts of American ginseng, 4 parts of Astragalus, 3 parts of Panax notoginseng, 6 parts of Ganoderma lucidum

[0046] Ligustrum lucidum 6 parts, Caulis Spatholobus 8 parts, Lycium barbarum 6 parts, Paeoniae Alba 5 parts

[0047] 5 parts of psoralen, 4 parts of donkey-hide gelatin, 6 parts of tangerine peel

[0048] Application of the above composition in the treatment of leukopenia.

[0049] The above composition can be made into any existing clinically applicable dosage form in pills, capsules, tablets, granules and oral liquids according to the prior art.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating leucopenia. The composition researched by using the basic theory of the traditional Chinese medicine consists of American ginseng, astragalus root, pseudo-ginseng, ganoderma lucidum, glossy privet fruit, suberect spatholobus stem, medlar, white peony root, fructus psoraleae, donkey-hide glue, dried orange peel and the like which are used as Chinese medicinal raw materials. The composition has the effects of nourishing liver and kidney and tonifying qi and blood, and is clinically used for treating the leucopenia produced after malignant tumor radiotherapy and chemotherapy.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating leukopenia, more specifically, a traditional Chinese medicine composition which has the functions of nourishing liver and kidney, benefiting qi and blood, and is used for leukopenia caused by radiotherapy and chemotherapy of malignant tumors, which belongs to medicine technology field. Background technique [0002] Leukopenia is a common blood disease and belongs to the category of asthenia and blood deficiency in traditional Chinese medicine. Doctor trained in Western medicine uses the medicine treatment such as batyl alcohol, lexogen, Ruibai more, but curative effect is relatively poor, and side effect is bigger. Although the granulocyte colony factor used in recent years has a certain curative effect, it is expensive and has many side effects, which limit the promotion of the drug. [0003] The TCM syndrome differentiation of leukopenia belongs to deficiency of both qi and blood, d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/815A61P7/00A61K35/36
Inventor 朱家红
Owner 朱家红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com